Media ReleasesLBT Innovations

View All LBT Innovations News

LBT Innovations - $1.5M Funding Awarded for New APAS Instrument

Adelaide, Australia, 24 October 2022: Australian medical technology company LBT Innovations Limited (ASX: LBT) (LBT or the Company), a leader in medical technology automation using artificial intelligence, is pleased to announce the Company has been awarded $1.5 million funding from the Australian Government’s Medical Research Future Fund (MRFF) initiative through MTPConnect’s Clinical Translation and Commercialisation Medtech (CTCM) program to support the development of a new smaller benchtop APAS® instrument (APAS® Compact).

Key Points:
-- APAS® Compact: Small low-cost benchtop instrument
---- Targeting largest market segment: Small-medium sized laboratories
---- Expands recurring revenue potential from licencing existing APAS® analysis modules (AI Software)
---- Development simplified and de-risked: Re-using critical APAS® components already developed
-- $1.5 million CTCM Funding enables LBT to accelerate planned APAS® Compact product development
-- Funding progresses strategy to bring digital microbiology to all laboratories globally
-- Project will include a detailed market assessment, concluding in Q1 CY23, to clarify development program

For more information, download the attached PDF.

Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?